These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11770041)

  • 1. Pretreatment with a deleted form of hepatocyte growth factor (dHGF) prevents the mortality of plasma-loss-induced hypovolemic shock in rats.
    Arisawa H; Fukui K; Imai E; Yamashita Y; Iga Y; Masunaga H
    Shock; 2001 Dec; 16(6):438-43. PubMed ID: 11770041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleted form of hepatocyte growth factor ameliorates the mortality rate of severe thermal injury in rats.
    Arisawa H; Yamashita Y; Ogawa H; Masunaga H; Higashio K
    Surgery; 1999 Nov; 126(5):925-32. PubMed ID: 10568193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of the effects of deletion variant of hepatocyte growth factor on hepatic ischaemia-reperfusion injury.
    Ikegami T; Nishizaki T; Uchiyama H; Hashimoto K; Yanaga K; Sugimachi K
    Br J Surg; 2000 Jan; 87(1):59-64. PubMed ID: 10606912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intravenous infusion of deleted form of hepatocyte growth factor attenuates hepatic ischemia-reperfusion injury in rats.
    Oe S; Hiros T; Fujii H; Yasuchika K; Nishio T; Iimuro Y; Morimoto T; Nagao M; Yamaoka Y
    J Hepatol; 2001 Jun; 34(6):832-9. PubMed ID: 11451166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deleted form of human hepatocyte growth factor stimulates hepatic lipogenesis and lipoprotein synthesis in rats.
    Shiota A; Yamashita Y; Fujise N; Masunaga H; Yasuda H; Higashio K
    Pharmacol Res; 2000 Nov; 42(5):443-52. PubMed ID: 11023706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant of deleted variant of hepatocyte growth factor (dHGF) with alanine substitution in the N-terminal basic region has higher activity in vivo.
    Kinosaki M; Yamaguchi K; Yamashita Y; Uematsu Y; Aihara H; Masunaga H; Morinaga T; Higashio K
    Biochem Biophys Res Commun; 1999 Jan; 254(2):363-7. PubMed ID: 9918843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion variant of hepatocyte growth factor prolongs allograft survival after liver transplantation in rats.
    Ikegami T; Nishizaki T; Uchiyama H; Kakizoe S; Yanaga K; Sugimachi K
    Surgery; 1999 Jun; 125(6):602-7. PubMed ID: 10372025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleted form of hepatocyte growth factor (dHGF) increases the number of platelets in rats with liver cirrhosis.
    Masunaga H; Fujise N; Yamashita Y; Shiota A; Yasuda H; Higashio K
    Liver; 1997 Aug; 17(4):192-7. PubMed ID: 9298489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective administration route for the deleted form of hepatocyte growth factor To exert its pharmacological effects.
    Uematsu Y; Fujise N; Kohsaka K; Masunaga H; Higashio K
    J Pharm Sci; 1999 Jan; 88(1):131-5. PubMed ID: 9874714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
    Yasuda H; Imai E; Shiota A; Fujise N; Morinaga T; Higashio K
    Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats.
    Masunaga H; Fujise N; Shiota A; Yamashita Y; Yasuda H; Higashio K
    J Pharm Pharmacol; 1996 Aug; 48(8):876-9. PubMed ID: 8887742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the deleted form of hepatocyte growth factor on serum hyaluronate levels in rats with liver cirrhosis.
    Yamashita Y; Shiota A; Fujise N; Ogawa H; Masunaga H; Yasuda H; Higashio K
    J Vet Med Sci; 1998 Mar; 60(3):359-60. PubMed ID: 9560786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deletion-type human hepatocyte growth factor on murine septic model.
    Kondo H; Tani T; Kodama M
    J Surg Res; 1999 Jul; 85(1):88-95. PubMed ID: 10383843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of scarred vocal folds using 5 amino acid-deleted type hepatocyte growth factor.
    Mizuta M; Hirano S; Ohno S; Kanemaru S; Nakamura T; Ito J
    Laryngoscope; 2014 Mar; 124(3):E81-6. PubMed ID: 24115162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of deletion variant of hepatocyte growth factor on reduced-size liver transplantation in rats.
    Uchiyama H; Yanaga K; Nishizaki T; Soejima Y; Yoshizumi T; Sugimachi K
    Transplantation; 1999 Jul; 68(1):39-44. PubMed ID: 10428264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of monocrotaline-induced hepatic injury by deleted variant of hepatocyte growth factor (dHGF) in rats.
    Yamashita Y; Fujise N; Imai E; Masunaga H
    Liver; 2002 Aug; 22(4):302-7. PubMed ID: 12296963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure.
    Shima N; Tsuda E; Goto M; Yano K; Hayasaka H; Ueda M; Higashio K
    Biochem Biophys Res Commun; 1994 Apr; 200(2):808-15. PubMed ID: 8179615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure.
    Chen Y; Kobayashi N; Suzuki S; Soto-Gutierrez A; Rivas-Carrillo JD; Tanaka K; Navarro-Alvarez N; Fukazawa T; Narushima M; Miki A; Okitsu T; Amemiya H; Tanaka N
    Transplantation; 2005 May; 79(10):1378-85. PubMed ID: 15912107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of diaspirin cross-linked hemoglobin on hemodynamics, metabolic acidosis, and survival in burned rats.
    Soltero RG; Hansbrough JF
    J Trauma; 1999 Feb; 46(2):286-91. PubMed ID: 10029035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of deletion variant of hepatocyte growth factor for impaired hepatic regeneration in the ischemically damaged liver.
    Okamoto K; Suzuki S; Kurachi K; Sunayama K; Yokoi Y; Konno H; Baba S; Nakamura S
    World J Surg; 2002 Oct; 26(10):1260-6. PubMed ID: 12205552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.